Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis: Results From an Open-Label, Long-Term Follow-up Study

被引：0

作者：

Brunner, Hermine ^{[1
]}

Ruperto, Nicolino ^{[2
]}

Quartier, Pierre ^{[3
]}

Constantin, Tamas ^{[2
]}

Alexeeva, Ekaterina ^{[2
]}

Schneider, Rayfel ^{[4
]}

Kone-Paut, Isabelle ^{[5
]}

Schikler, Kenneth N. ^{[4
]}

Marzan, Katherine ^{[4
]}

Wulffraat, Nico ^{[2
]}

Padeh, Shai ^{[2
]}

Chasnyk, Vyacheslav ^{[2
]}

Wouters, Carine ^{[2
]}

Kuemmerle-Deschner, Jasmin B. ^{[2
]}

Kallinich, Tilmann ^{[2
]}

Lauwerys, Bernard ^{[6
,7
]}

Haddad, Elie ^{[4
]}

Nasonov, Evgeny L. ^{[2
]}

Trachana, Maria ^{[2
]}

Vougiouka, Olga ^{[2
]}

Leon, Karolynn ^{[8
]}

Speziale, Antonio ^{[9
]}

Lheritier, Karine ^{[9
]}

Vritzali, Eleni ^{[10
]}

Martini, Alberto ^{[2
]}

Lovell, Daniel ^{[4
]}

机构：

[1] PRCSG, Rheumatol, Cincinnati, OH USA

[2] PRINTO Ist Gaslini, Genoa, Italy

[3] Necker Enfants Malad Hosp, Paris, France

[4] PRCSG, Cincinnati, OH USA

[5] Univ Paris Sud, Hop Kremlin Bicetre, Paris, France

[6] Clin Univ St Luc, Brussels, Belgium

[7] Catholic Univ Louvain, Brussels, Belgium

[8] Novartis Pharmaceut, E Hanover, NJ USA

[9] Novartis Pharma AG, Basel, Switzerland

[10] Novartis Pharma AG, Immunol & Dermatol Franchise, Basel, Switzerland

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：7 / 8

页数：2

共 3 条

[1] 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications [J].

Ringold, Sarah ;

Weiss, Pamela F. ;

Beukelman, Timothy ;

DeWitt, Esi Morgan ;

Ilowite, Norman T. ;

Kimura, Yukiko ;

Laxer, Ronald M. ;

Lovell, Daniel J. ;

Nigrovic, Peter A. ;

Robinson, Angela Byun ;

Vehe, Richard K. .

ARTHRITIS AND RHEUMATISM, 2013, 65 (10) :2499-2512

[2] EFFICACY AND SAFETY OF CANAKINUMAB IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS WITH AND WITHOUT FEVER [J].

Ruperto, N. ;

Brunner, H. ;

Quartier, P. ;

Constantin, T. ;

Alexeeva, E. ;

Kone-Paut, I. ;

Marzan, K. ;

Wulffraat, N. ;

Schneider, R. ;

Padeh, S. ;

Chasnyk, V. ;

Wouters, C. ;

Deschner, J. Kummerle ;

Kallinich, T. ;

Lauwerys, B. ;

Haddad, E. ;

Nasonov, E. ;

Trachana, M. ;

Vougiouka, O. ;

Abrams, K. ;

Leon, K. ;

Lheritier, K. ;

Martini, A. ;

Lovell, D. .

ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 :608-608

[3] Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis [J].

Ruperto, Nicolino ;

Brunner, Hermine I. ;

Quartier, Pierre ;

Constantin, Tamas ;

Wulffraat, Nico ;

Horneff, Gerd ;

Brik, Riva ;

McCann, Liza ;

Kasapcopur, Ozgur ;

Rutkowska-Sak, Lidia ;

Schneider, Rayfel ;

Berkun, Yackov ;

Calvo, Inmaculada ;

Erguven, Muferet ;

Goffin, Laurence ;

Hofer, Michael ;

Kallinich, Tilmann ;

Oliveira, Sheila K. ;

Uziel, Yosef ;

Viola, Stefania ;

Nistala, Kiran ;

Wouters, Carine ;

Cimaz, Rolando ;

Ferrandiz, Manuel A. ;

Flato, Berit ;

Gamir, Maria Luz ;

Kone-Paut, Isabelle ;

Grom, Alexei ;

Magnusson, Bo ;

Ozen, Seza ;

Sztajnbok, Flavio ;

Lheritier, Karine ;

Abrams, Ken ;

Kim, Dennis ;

Martini, Alberto ;

Lovell, Daniel J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25) :2396-2406

← 1 →